Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301

NCT02211508 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
236
Enrollment
INDUSTRY
Sponsor class

Stopped Trial terminated Feb '15. Interim analysis results missed primary endpoint, intended signal not delivered in Tx arm, sham results as expected. No safety issues.

Conditions

Interventions

Sponsor

Cerephex Corporation